Relapsed Or Refractory Plasmablastic Lymphoma clinical trials

Explore recruiting relapsed or refractory plasmablastic lymphoma clinical trials.

Recruiting relapsed or refractory plasmablastic lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Or Refractory Plasmablastic Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open Label, Phase 2 Study to Evaluate Activity and Safety of Daratumumab in combination with Bortezomib and Dexamethasone in patients with Relapsed or Refractory Plasmablastic lymphoma (DALYA trial)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Relapsed Or Refractory Plasmablastic Lymphoma trials by city

Relapsed Or Refractory Plasmablastic Lymphoma in Toronto Relapsed Or Refractory Plasmablastic Lymphoma in Vancouver Relapsed Or Refractory Plasmablastic Lymphoma in Montreal Relapsed Or Refractory Plasmablastic Lymphoma in Calgary Relapsed Or Refractory Plasmablastic Lymphoma in Edmonton Relapsed Or Refractory Plasmablastic Lymphoma in Ottawa Relapsed Or Refractory Plasmablastic Lymphoma in Winnipeg Relapsed Or Refractory Plasmablastic Lymphoma in Quebec City Relapsed Or Refractory Plasmablastic Lymphoma in Hamilton Relapsed Or Refractory Plasmablastic Lymphoma in Kitchener Relapsed Or Refractory Plasmablastic Lymphoma in London Relapsed Or Refractory Plasmablastic Lymphoma in Halifax Relapsed Or Refractory Plasmablastic Lymphoma in New York Relapsed Or Refractory Plasmablastic Lymphoma in Los Angeles Relapsed Or Refractory Plasmablastic Lymphoma in Chicago Relapsed Or Refractory Plasmablastic Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease